Expression of transforming growth factor-β receptor type 1 and type 2 in human sporadic vestibular Schwannoma

Pathology Research and Practice

Volumn 203, Issue 4, 2007, Pages 245-249

  Löttrich, Mathias ^a   Mawrin, Christian ^a,b   Chamaon, Kathrin ^a   Kirches, Elmar ^a   Dietzmann, Knut ^a   Freigang, Bernd ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Immunohistochemistry; RT PCR; Schwannoma; TGF receptor

Indexed keywords

BETA 2 MICROGLOBULIN; KI 67 ANTIGEN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ARTICLE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEURILEMOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 34247255965     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2006.12.007     Document Type: Article

References (23)

1. Bizzarri M., Filipo R., Valente M.G., Bernardeschi D., Ronchetti F., Monini S., Chiappini I., and Barbara M. Release of transforming growth factor beta-1 in a vestibular schwannoma cell line. Acta Otolaryngol. 122 (2002) 785-787
2. Cardillo M.R., Filipo R., Monini S., Aliotta N., and Barbara M. Transforming growth factor-beta1 expression in human acoustic neuroma. Am. J. Otol. 20 (1999) 65-68
3. Casadei G.P., Komori T., Scheithauer B.W., Miller G.M., Parisi J.E., and Kelly P.J. Intracranial parenchymal schwannoma. A clinicopathological and neuroimaging study of nine cases. J. Neurosurg. 79 (1993) 217-222
4. Cerullo L., Grutsch J., and Osterdock R. Recurrence of vestibular (acoustic) schwannomas in surgical patients where preservation of facial and cochlear nerve is the priority. Br. J. Neurosurg. 12 (1998) 547-552
5. Charabi S., Engel P., Charabi B., Jacobsen G.K., Overgaard J., Thomsen J., and Tos M. Growth of vestibular schwannomas: in situ model employing the monoclonal antibody Ki-67 and DNA flow cytometry. Am. J. Otol. 17 (1996) 301-306
6. Diensthuber M., Brandis A., Lenarz T., and Stover T. Co-expression of transforming growth factor-beta1 and glial cell line-derived neurotrophic factor in vestibular schwannoma. Otol. Neurotol. 25 (2004) 359-365
7. Kim J.H., Shariat S.F., Kim I.Y., Menesses-Diaz A., Tokunaga H., Wheeler T.M., and Lerner S.P. Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder. Cancer 92 (2001) 1475-1483
8. Kondziolka D., Lunsford L.D., McLaughlin M.R., and Flickinger J.C. Long-term outcomes after radiosurgery for acoustic neuromas. N. Engl. J. Med. 339 (1998) 1426-1433
9. Lee F., Linthicum Jr. F., and Hung G. Proliferation potential in recurrent acoustic schwannoma following gamma knife radiosurgery versus microsurgery. Laryngoscope 112 (2002) 948-950
10. Marushige K., and Marushige Y. Induction of apoptosis by transforming growth factor beta 1 in glioma and trigeminal neurinoma cells. Anticancer Res. 14 (1994) 2419-2424
11. Marushige K., and Marushige Y. Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis. Anticancer Res. 19 (1999) 3865-3871
12. Mawrin C., Kirches E., Dietzmann K., Roessner A., and Boltze C. Expression pattern of apoptotic markers in vestibular schwannomas. Pathol. Res. Pract. 198 (2002) 813-819
13. Mawrin C., Schulz S., Hellwig-Patyk A., Kirches E., Roessner A., Lendeckel U., Firsching R., Vorwerk C.K., Keilhoff G., Dietzmann K., Grimm K., Lindberg G., Gutmann D.H., Scheithauer B.W., and Perry A. Expression and function of somatostatin receptors in peripheral nerve sheath tumors. J. Neuropathol. Exp. Neurol. 64 (2005) 1080-1088
14. Meikle A.W., Swope R.E., Yin D.Y., Fullmer D., Loop S.M., and Murray D.K. Transforming growth factor beta-1 and beta-2 and type II receptor functional regulation of ALVA-101 human prostate cancer cells. Metabolism 48 (1999) 1075-1081
15. Norgaard P., Spang-Thomsen M., and Poulsen H.S. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines. Br. J. Cancer 73 (1996) 1037-1043
16. Seoane J. Escaping from the TGF{beta} anti-proliferative control. Carcinogenesis (2006)
17. Skoff A.M., Lisak R.P., Bealmear B., and Benjamins J.A. TNF-alpha and TGF-beta act synergistically to kill Schwann cells. J. Neurosci. Res. 53 (1998) 747-756
18. Stark B., Carlstedt T., and Risling M. Distribution of TGF-beta, the TGF-beta type I receptor and the R-II receptor in peripheral nerves and mechanoreceptors; observations on changes after traumatic injury. Brain Res. 913 (2001) 47-56
19. Stonecypher M.S., Chaudhury A.R., Byer S.J., and Carroll S.L. Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis. J. Neuropathol. Exp. Neurol. 65 (2006) 162-175
20. Ten Dijke P., Goumans M.J., Itoh F., and Itoh S. Regulation of cell proliferation by Smad proteins. J. Cell Physiol. 191 (2002) 1-16
21. Weerda H.G., Gamberger T.I., Siegner A., Gjuric M., and Tamm E.R. Effects of transforming growth factor-beta1 and basic fibroblast growth factor on proliferation of cell cultures derived from human vestibular nerve schwannoma. Acta Otolaryngol. 118 (1998) 337-343
22. Woodruff J.M., Selig A.M., Crowley K., and Allen P.W. Schwannoma (neurilemoma) with malignant transformation. A rare, distinctive peripheral nerve tumor. Am. J. Surg. Pathol. 18 (1994) 882-895
23. Yohay K. Neurofibromatosis types 1 and 2. Neurologist 12 (2006) 86-93